Home › Hypertrophic Cardiomyopathy › Texas › Houston
Hypertrophic Cardiomyopathy clinical trials in Houston, TX
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- BI Research Center, Houston
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
RecruitingPhase 2
- Imbria Investigational Site, Houston
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
RecruitingPhase 1/2
- Houston Methodist Hospital, Houston
Hypertrophic Cardiomyopathy trials in other cities
- Boston, MA6 studies
- San Francisco, CA4 studies
- Charlottesville, VA4 studies
- Cleveland, OH4 studies
- New York City, NY3 studies
- Chicago, IL3 studies
- San Diego, CA3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.